Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Granule for treating pediatric allergic purpura digestive tract symptom

A technology for allergic purpura, digestive tract, applied in allergic diseases, digestive system, organic active ingredients, etc., can solve the problems of not easy to relapse, easy to relapse, long course of disease, etc., to enhance resistance, relieve pain, and prevent malignant development. Effect

Inactive Publication Date: 2016-11-23
钟志敏
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, there is no effective treatment for this disease. In the acute stage, bed rest is required, and the diet should be based on liquid food. The current drug therapy is mainly to control symptoms, and the course of disease is long and easy to relapse. Only by regulating the constitution of the child from the inside and enhancing its own immunity can the onset of the disease be effectively controlled and the goal of preventing recurrence

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] The granule for treating allergic purpura gastrointestinal symptoms in children mainly consists of the following components by weight: 0.3 parts of L-glutamine, 2.1 parts of hyperoside, 1.6 parts of asparagine, 1.4 parts of element A, 1.3 parts of arginine, 1.1 parts of isoimperatorin, 0.7 parts of morolicin, 0.5 parts of betulin, 0.4 parts of crocin, 0.3 parts of polysaccharide hydrolyzate, 0.2 parts of stigmasterol, magnolia flower 0.1 part of alkali, 0.08 part of nicotinamide, 0.06 part of calcium pantothenate, 0.005 part of rutin, 0.002 part of vitamin C, and the following auxiliary materials: 5 parts of filler, 3 parts of binder, 0.4 part of disintegrant, 0.2 part of lubricant share.

[0018] The preparation method of the granule for the treatment of children's anaphylactic purpura digestive tract symptoms is as follows:

[0019] Step 1: Dissolving the polysaccharide hydrolyzate of the weight component with 4 times the amount of water, adding 3.5% by weight surfac...

Embodiment 2

[0023] The granule for treating allergic purpura gastrointestinal symptoms in children mainly consists of the following components by weight: 0.5 parts of L-glutamine, 3.7 parts of hyperoside, 3.2 parts of asparagine, 2.8 parts of element A, 2.6 parts of arginine, 3.3 parts of isoimperatorin, 1.85 parts of moronidin, 1.6 parts of betulin, 1.3 parts of crocin, 1.05 parts of polysaccharide hydrolyzate, 0.8 parts of stigmasterol, magnolia flower 0.6 parts of alkali, 0.44 parts of nicotinamide, 0.28 parts of calcium pantothenate, 0.011 parts of rutin, 0.007 parts of vitamin C, and 12 parts of fillers, 8.5 parts of binders, 0.9 parts of disintegrants, and 0.45 parts of lubricants.

[0024] The preparation method of the granule for the treatment of children's anaphylactic purpura digestive tract symptoms is as follows:

[0025] Step 1: Dissolving the polysaccharide hydrolyzate of the weight component with 5 times the amount of water, adding 3.5% by weight of surfactant to the obtain...

Embodiment 3

[0029] The granule for treating allergic purpura gastrointestinal symptoms in children mainly consists of the following ingredients in parts by weight: 0.7 parts of L-glutamine, 5.3 parts of hyperoside, 4.8 parts of asparagine, 4.2 parts of element A, 3.9 parts of arginine, 3.5 parts of isoimperatorin, 3.0 parts of morolicin, 2.7 parts of betulin, 2.2 parts of crocin, 1.8 parts of polysaccharide hydrolyzate, 1.4 parts of stigmasterol, magnolia flower 1.1 parts of alkali, 0.8 parts of nicotinamide, 0.5 parts of calcium pantothenate, 0.017 parts of rutin, 0.012 parts of vitamin C, and the following auxiliary materials: 19 parts of fillers, 14 parts of binders, 1.4 parts of disintegrants, 0.7 parts of lubricants share.

[0030] The preparation method of the granule for the treatment of children's anaphylactic purpura digestive tract symptoms is as follows:

[0031] Step 1: dissolving the polysaccharide hydrolyzate of the weight component with 6 times the amount of water, adding ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a granule for treating pediatric allergic purpura digestive tract symptom. The granule for treating the pediatric allergic purpura digestive tract symptom is mainly prepared from the following components: L-glutamine, hyperin, asparagines, rabdosia excise A, skimmianine, isoimperatorin, morroniside, betulin, crocin, polysaccharide hydrolysate, stigmasterol, magnoflorine, nicotinamide, calcium pantothenate, rutin, vitamin C, a filler, a binding agent, a disintegrating agent, and a lubricating agent. The granule is used for treating digestive tract symptoms caused by the pediatric allergic purpura, is antibacterial and anti-inflammatory, and has the functions of easing pain and eliminating blood stasis, reinforcing the body cell immunity, supplementing nutrition absorbing battier caused by gastroenteritis, and protecting gastrointestinal tract mucous membrane, thereby releasing gastric dysfunction caused by pediatric gastrointestinal weakness, and avoiding generation of complications, such as ileus and perforation.

Description

technical field [0001] The invention relates to the technical field of pediatric medication, in particular to granules for treating the digestive tract symptoms of allergic purpura in children. Background technique [0002] Allergic purpura in children is the most common capillary allergic disease. It is based on extensive small vessel inflammation. The main clinical manifestations are skin purpura, gastrointestinal mucosal bleeding, joint swelling and nephritis. Children, especially school-age children, are more affected. According to statistics, the youngest child is only 3 months old, and has a significant seasonality. The incidence is more frequent in winter and spring, and less in summer. The etiology of this disease is complex, and the symptoms of the disease are also different, which also increases the difficulty of treatment. The main pathogenic factors include infection, food, medicine, pollen, insect bites, vaccination, etc., which make the body with sensitive qual...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61K31/375A61K31/37A61P1/00A61P37/08
CPCA61K31/37A61K31/375A61K31/7048A61K2300/00
Inventor 钟志敏
Owner 钟志敏
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com